Overview
To develop and validate a novel disease-specific questionnaire for measuring HRQoL in patients with Chronic Pulmonary Aspergillosis (CPA-HAQ) for use in clinical research, including clinical trials.
Eligibility
Inclusion Criteria:
- All patients >/= 18 years old and able to provide informed consent
- Patients with a diagnosis of chronic pulmonary aspergillosis
- To speak and understand English
- Able to provide informed consent